Remote inspections prompt drop in data integrity citations in FY2021

The inability to conduct onsite inspections impeded investigators’ ability to uncover data integrity issues at manufacturing sites in drug warning letters in FY2021, underscoring the importance of onsite inspections, said US Food and Drug Administration (FDA) consumer safety officer Maan Abduldayem.